Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144

NCT01435135 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

162

Enrollment

FED

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: ALVAC-HIV
BIOLOGICAL: AIDSVAX B/E
BIOLOGICAL: ALVAC-HIV Placebo
BIOLOGICAL: AIDSVAX B/E Placebo

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]